In vitamin D-deficient overweight or obese kids aged 10 to 18, taking 1000–2000 IU of vitamin D3 daily for six months lowers blood sugar and blood pressure and helps the body use insulin better, even though it doesn't change artery health or inflammation markers.
Mechanism
1 studyGiving vitamin D3 to vitamin D-deficient overweight children increases active vitamin D in their bodies, which turns on more insulin receptors and glucose transporters in muscle and fat cells, pulling glucose out of the blood and lowering blood sugar levels.
Giving vitamin D3 to vitamin D-deficient overweight children increases active vitamin D in their bodies, which turns on more insulin receptors and glucose transporters in muscle and fat cells, pulling glucose out of the blood and lowering blood sugar levels.
Oral vitamin D3 is absorbed and converted in the liver to 25-hydroxyvitamin D, which circulates in the blood at higher concentrations with increased dosage.
25-hydroxyvitamin D is converted in the kidneys to its active form, 1,25-dihydroxyvitamin D, which binds to vitamin D receptors in skeletal muscle, adipose tissue, and pancreatic beta cells.
Activation of vitamin D receptors increases the expression of insulin receptors and promotes the translocation of GLUT4 glucose transporters to the cell membrane in muscle and fat cells.
Increased GLUT4 activity enhances glucose uptake from the bloodstream into muscle and fat cells, reducing circulating glucose concentration and decreasing insulin demand.
Evidence from Studies
Supporting (2)
Community contributions welcome
Effect of vitamin D3 supplementation on vascular and metabolic health of vitamin D-deficient overweight and obese children: a randomized clinical trial.
This study found that giving vitamin D supplements to overweight kids with low vitamin D levels helped lower their blood sugar and blood pressure, even though their blood vessels and inflammation didn’t change. So yes, the vitamin D helped in the ways the claim says.
Effect of Vitamin D3 Supplementation on Insulin Sensitivity in Prediabetes With Hypovitaminosis D: A Randomized Placebo-Controlled Trial
This study found that giving vitamin D to people with low vitamin D levels and prediabetes helped their bodies use insulin better and lowered their fasting blood sugar. While it didn’t test kids or exactly the same dose, it still supports the idea that vitamin D can help with blood sugar in people who are deficient.
Contradicting (1)
Community contributions welcome
Can vitamin D supplementation affect cardiometabolic factors in children and adolescence with overweight and obesity? A grade-assessed systematic review and meta-analysis of randomized controlled trials
This study looked at whether giving vitamin D to overweight kids helps lower their blood sugar and improve how their body uses insulin. It found no such benefits — so the claim that vitamin D helps is not supported by this research.
Connected Assertions (1)
These assertions contribute to the insight.
Supporting (1)
Sign up to explore supporting evidence
Contrary (0)
Sign up to explore contrary evidence
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Vitamin D3 Supplementation on Glucose Metabolism and Blood Pressure in Vitamin D-Deficient Overweight and Obese Children Aged 10–18
Population: Vitamin D-deficient overweight and obese children aged 10–18; Intervention: Daily vitamin D3 supplementation at 1000–2000 IU for six months; Comparator: Placebo; Outcomes: Fasting glucose, blood pressure, insulin sensitivity (HOMA-IR), arterial endothelial function, systemic inflammation markers; Duration: Six months.
Double-Blind, Placebo-Controlled Trial of 1000–2000 IU Vitamin D3 Daily for Six Months on Glucose, Blood Pressure, and Insulin Sensitivity in Vitamin D-Deficient Overweight and Obese Children Aged 10–18
Population: Vitamin D-deficient overweight and obese children aged 10–18; Intervention: Daily vitamin D3 at 1000–2000 IU; Comparator: Placebo; Outcomes: Fasting glucose, systolic/diastolic blood pressure, HOMA-IR, endothelial function (e.g., flow-mediated dilation), CRP and IL-6 levels; Duration: Six months; Design: Double-blind, randomized, parallel-group.
Prospective Cohort Study of Vitamin D3 Supplementation and Metabolic Outcomes in Vitamin D-Deficient Overweight and Obese Children Aged 10–18 Over Six Months
Population: Vitamin D-deficient overweight and obese children aged 10–18; Exposure: Daily vitamin D3 supplementation at 1000–2000 IU for six months; Comparator: Non-supplemented controls; Outcomes: Fasting glucose, blood pressure, HOMA-IR, endothelial function, inflammation markers measured at baseline and six months; Duration: Six months.
Cross-Sectional Analysis of Vitamin D Status, Fasting Glucose, Blood Pressure, and Insulin Sensitivity in Overweight and Obese Children Aged 10–18
Population: Vitamin D-deficient overweight and obese children aged 10–18; Exposure: Baseline vitamin D status; Outcomes: Fasting glucose, blood pressure, HOMA-IR, endothelial function, inflammation markers measured simultaneously; Duration: Single time point.
In Vitro Effects of Physiological Concentrations of Vitamin D3 on Human Hepatocyte Glucose Production and Endothelial Cell Function
Population: Human hepatocytes and endothelial cells; Intervention: Exposure to 10–100 nM calcitriol (active vitamin D); Comparator: Vehicle control; Outcomes: Glucose output, insulin signaling pathway activation, nitric oxide production, inflammatory cytokine release; Duration: 24–72 hours.
Related Claims
Claims semantically close to this one, ordered by similarity.